Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease and fibrosis in recently diagnosed type 2 diabetes

Table 5 Logistic regression to evaluate the risk factors associated with presence of liver fibrosis

Univariate	OR	95%CI	β	P value
Age	1.006	0.988-1.024	0.006	0.508
BMI class	1.783	1.492-2.131	0.578	< 0.001
Sex	0.809	0.551-1.187	-0.212	0.278
HbA1c ≥ 6.5%	1.664	1.074-2.580	0.509	0.023
Steatosis (CAP)	2.995	2.060-4.355	1.097	< 0.001
Triglycerides mg/dL	1.000	0.998-1.002	0.000	0.816
LDL cholesterol	0.994	0.988-1.001	-0.006	0.073
High AST	12.925	8.121-20.572	2.559	< 0.001
High ALT	6.681	4.160-10.729	1.899	< 0.001
GGT	1.026	1.019-1.032	0.025	< 0.001
Multivariate
BMI Class	1.500	1.169-1.924	0.405	0.001
HbA1c ≥ 6.5%	1.309	0.765-2.242	0.269	0.326
Steatosis (CAP)	1.965	1.162-3.324	0.676	0.012
High AST	4.180	2.314-7.549	1.430	< 0.001
High ALT	2.193	1.184-4.061	0.785	0.013
GGT	1.021	1.013-1.028	0.020	< 0.001

BMI: Body mass index; FAST: FibroScan-AST; LDL: Low-density cholesterol; HDL: High-density cholesterol; TGC: Triglycerides; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; HbA1c: Glycated hemoglobin; CAP: Controlled attenuation parameter; OR: Odds ratio; CI: Confidence interval.